Miscellaneous

27
Apr

Myeloid Cell Profiling – Naked Immunology Webinar 2

Welcome back to the Naked Immunology Webinar Series! Immunology is a broad subject moving fast. The Naked Immunology webinar series is here to help you stay up-to-date, with real science from expert speakers with a proven track record in the field. Join us on this journey into immunology and discover how recent trends can lead to better and safer drug
Read more
18
Feb

Naked Immunology – Webinar 1 – MRGPRX2+ Mast Cells

WELCOME TO THE NAKED IMMUNOLOGY WEBINAR SERIES! Immunology is a broad subject moving fast. The Naked Immunology webinar series is here to help you stay up-to-date, with real science from expert speakers with a proven track record in the field. Join us on this journey into immunology and discover how recent trends can lead to better and safer drug development.
Read more
16
Oct

Genoskin awarded the Healthtech prize “Transformons la France!”

Genoskin awarded the Healthtech prize “Transformons la France!” Yesterday, Genoskin was awarded the Healthtech prize at the “Transformons la France!” (Let’s Transform France!) ceremony presented by La Tribune in Toulouse. While the current health crisis calls into question our lifestyles, "Transformons la France!" highlights the talents of tomorrow and gives impact to those who transform society for the better. The
Read more
13
Aug

Genoskin in the News: article on Benzinga

Genoskin in the News: article on Benzinga Benzinga biotech reporter Shanthi Rexaline recently spoke to GENOSKIN's CEO Pascal Descargues. In the interview, Pascal shared the inspiration behind founding Genoskin: Pascal quickly realized during his postdoctoral fellowship that animal models were not predictive enough. Pascal also had the opportunity to present Genoskin’s technology. He walked Shanthi through the Genoskin workflow: from sourcing
Read more
16
May

Genoskin featured in a Business Insider article

Genoskin featured in a Business Insider article The press is talking about Genoskin! Amid COVID-19 breakout, Genoskin got attention from Business Insider 's reporter Mia Jankowicz.  We recently communicated on our continued efforts during the pandemic and our preferred access program for research on COVID-19. Genoskin's projects and technology caught the eye of Mia Jankowicz. Mia, a journalist specializing in
Read more
13
Mar

Genoskin supports CoViD19 research!

Genoskin COVID-19 research preferred access program On Friday, March 13th 2020, Genoskin launched a preferred access program for all research teams actively developing therapeutic and vaccine technologies for the COVID-19 pandemic. The World Health Organization (WHO) officially declared on March 11th, the outbreak of COVID-19 a pandemic. The disease caused by SARS-CoV-2 has spread globally. Over 130,000 individuals are affected so

Read more